Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy

Irina Negut,Bogdan Bita
DOI: https://doi.org/10.3390/pharmaceutics16040463
IF: 6.525
2024-03-27
Pharmaceutics
Abstract:This review addresses the urgent need for more targeted and less toxic cancer treatments by exploring the potential of multi-responsive polymersomes. These advanced nanocarriers are engineered to deliver drugs precisely to tumor sites by responding to specific stimuli such as pH, temperature, light, hypoxia, and redox conditions, thereby minimizing the side effects associated with traditional chemotherapy. We discuss the design, synthesis, and recent applications of polymersomes, emphasizing their ability to improve therapeutic outcomes through controlled drug release and targeted delivery. Moreover, we highlight the critical areas for future research, including the optimization of polymersome–biological interactions and biocompatibility, to facilitate their clinical adoption. Multi-responsive polymersomes emerge as a promising development in nanomedicine, offering a pathway to safer and more effective cancer treatments.
pharmacology & pharmacy
What problem does this paper attempt to address?
This paper aims to solve the problems of targeting and toxic side effects in cancer treatment. Traditional chemotherapy drugs, due to their lack of specificity, not only destroy tumor cells but also cause significant toxic side effects on healthy tissues, which greatly limits their clinical applications. To solve this problem, the paper explores the potential of multi - responsive polymersomes as an innovative stimulus - responsive platform in cancer treatment. Multi - responsive polymersomes are advanced nanocarriers designed to precisely deliver drugs to tumor sites by responding to specific stimuli (such as pH, temperature, light, hypoxia, and redox conditions), thereby minimizing the side effects of traditional chemotherapy. The paper discusses the design, synthesis, and recent applications of these polymersomes, with particular emphasis on their ability to improve treatment outcomes through controlled drug release and targeted delivery. In addition, the paper also points out key areas for future research, including optimizing the interaction and biocompatibility of polymersomes with organisms to promote their clinical applications. Through these methods, multi - responsive polymersomes are expected to become a promising development direction in nanomedicine, providing a way for safer and more effective cancer treatment methods.